Medtronic’s VenaSeal Closure System Evaluated for Superficial Venous Disease in Spectrum Program – Endovascular Today
April 24, 2024—Medtronic announced primary endpoint and 30-day modified Aberdeen Varicose Vein Questionnaire (AVVQ) findings from the VenaSeal S